LYMPHOMA, B-CELL
Clinical trials for LYMPHOMA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat lymphomas
Disease control TerminatedThis study tested a combination of two drugs, favezelimab and pembrolizumab, in 137 people with certain blood cancers like Hodgkin lymphoma and B-cell lymphoma. The goal was to see if the combination was safe and could shrink tumors. The study also looked at each drug alone in so…
Matched conditions: LYMPHOMA, B-CELL
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Experimental combo therapy for tough lymphoma shows promise but trial halted early
Disease control TerminatedThis Phase 2 trial tested a two-step treatment for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. First, patients received a stem cell transplant using their own cells, followed by an infusion of CAR-T cells (a type of immune cell therapy). The goal was to se…
Matched conditions: LYMPHOMA, B-CELL
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC